Joseph Edelman – XENE history
- Issuer:
- XENON PHARMACEUTICALS INC
- Quarters tracked:
- 27 (Q2 2016 → Q1 2026)
- Current shares:
- 0
- Current value:
- $0
- Peak shares:
- 2,411,447 (Q4 2021)
- Overall change:
- -100%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | SOLD | — | — | -200,791 | -100% |
| Q4 2025 | 200,791 | $9.00M | $44.82 | 0 | 0% |
| Q3 2025 | 200,791 | $8.06M | $40.15 | 0 | 0% |
| Q2 2025 | 200,791 | $6.29M | $31.30 | -124,533 | -38% |
| Q1 2025 | 325,324 | $10.91M | $33.55 | 0 | 0% |
| Q4 2024 | 325,324 | $12.75M | $39.20 | -199,606 | -38% |
| Q3 2024 | 524,930 | $20.67M | $39.37 | -58,326 | -10% |
| Q2 2024 | 583,256 | $22.74M | $38.99 | -308,952 | -35% |
| Q1 2024 | 892,208 | $38.41M | $43.05 | -208,540 | -19% |
| Q4 2023 | 1,100,748 | $50.70M | $46.06 | +483,248 | +78% |
| Q3 2023 | 617,500 | $21.09M | $34.16 | -605,877 | -50% |
| Q2 2023 | 1,223,377 | $47.10M | $38.50 | -608,797 | -33% |
| Q1 2023 | 1,832,174 | $65.57M | $35.79 | -89,099 | -5% |
| Q4 2022 | 1,921,273 | $75.76M | $39.43 | -201,262 | -9% |
| Q3 2022 | 2,122,535 | $76.62M | $36.10 | 0 | 0% |
| Q2 2022 | 2,122,535 | $64.57M | $30.42 | -288,912 | -12% |
| Q1 2022 | 2,411,447 | $73.72M | $30.57 | 0 | 0% |
| Q4 2021 | 2,411,447 | $75.33M | $31.24 | +389,396 | +19% |
| Q3 2021 | 2,022,051 | $30.90M | $15.28 | +343,078 | +20% |
| Q2 2021 | 1,678,973 | $31.26M | $18.62 | +1,163,931 | +226% |
| Q1 2021 | 515,042 | $9.22M | $17.90 | +515,042 | +100% |
| Q3 2017 | SOLD | — | — | -723,853 | -100% |
| Q2 2017 | 723,853 | $2.28M | $3.15 | 0 | 0% |
| Q1 2017 | 723,853 | $2.90M | $4.00 | -16,419 | -2% |
| Q4 2016 | 740,272 | $5.70M | $7.70 | -22,528 | -3% |
| Q3 2016 | 762,800 | $6.18M | $8.10 | +330,000 | +76% |
| Q2 2016 | 432,800 | $2.55M | $5.90 | — | NEW |